Home » Bone Marrow Transplantation Market

Bone Marrow Transplantation Market By Type (Allogeneic Bone Marrow Transplant, Autologous Bone Marrow Transplant), By Indication (Leukemia, Lymphoma, Myeloma and Others) – Growth, Future Prospects & Competitive Analysis, 2018 – 2026

Price: $4999

Published: | Report ID: 3269 | Report Format : PDF

Industry Outlook

The bone marrow transplantation market is expected to grow from US$ 8,356.4 million in 2017 to US$ 13,903.1 million by 2026, exhibiting straightforward growth at a compound annual growth rate (CAGR) of 5.9% from 2018 to 2026. According to the research findings provided by Bristol-Myers Squibb Company, by 2040, there will be 1.85 million new cases of blood cancer reported worldwide.

Market Synopsis

Lowering the risk of disease recurrence and a significant increase in the number of healthy donors are driving the growth of the allogeneic bone marrow transplant market.

Allogeneic bone marrow transplants are currently dominating the type segment of the bone marrow transplantation market. The graft is free from contaminating tumor cells, and the immunocompetent cells derived from a healthy donor may produce an immune graft versus malignancy effect. A significant rise in the number of healthy donors and a lower risk of disease recurrence together drive the allogeneic bone marrow transplant market. Autologous bone marrow transplant will be capturing the market in the near future owing to the increasing number of stem cell banks that store healthy cells from patients and, after conditioning treatment, are introduced into the patient to produce healthy blood cells.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample
CTA Design Element 3

The lymphoma indication market is growing due to an increase in the number of new cases of Hodgkin lymphoma patients and improved survival rates following bone marrow transplantation.

Lymphoma is currently reigning as the indication segment for the bone marrow transplantation market. It is of two types: Hodgkin lymphoma and non-Hodgkin lymphoma. The National Cancer Institute (NCI) reported 83,180 new cases of lymphoma in 2018. A significant rise in lymphoma patients and better survival rates post-bone marrow transplantation drive the lymphoma indications market’s growth. Leukemia is the abnormal production of white blood cells in the bone marrow. The National Cancer Institute (NCI) reported 60,300 new cases of leukemia in 2018.

In North America, market growth is being driven by the rising prevalence of chronic lymphocytic leukemia and the presence of sophisticated healthcare infrastructure.

In the present scenario, North America, with a revenue share of 38%, is the clear leader in the bone marrow transplantation market. The chief parameters contributing to its market success are the rising prevalence of chronic lymphocytic leukemia. According to American Cancer Society (ACS) research findings in 2019, it is estimated that approximately 20,720 new cases of chronic lymphocytic leukemia will be reported in North America. The prevalence rate is slightly higher in men in comparison to women. The presence of sophisticated healthcare infrastructure further consolidates market growth in the North American region.

Due to the increasing number of patients suffering from multiple myeloma, Europe is in second place, accounting for 32% of the market share. As per the latest report provided by Myeloma Patients Europe (MPE), by 2025, the number of patients suffering from multiple myeloma will be around 46,000. The domicile of major players such as Lonza Group Ltd., Merck Millipore Corporation, and PromoCell GmbH further bolsters market growth in Europe. Currently, Asia Pacific holds 20% of the market share on account of proactive government policies to curb the mortality rate associated with blood cancer and technological advancements in the bone marrow transplantation technique.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments is calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The market is segmented by type, indication, and geography.

Biotechnology firms actively engaged in bone marrow transplantation procedures are AllCells LLC, Conversant Bio, Cellular Dynamics International, Gamida Cell Ltd., Hemacare Corporation, Lonza Group Ltd., Merck Millipore Corporation, Mesoblast Ltd., PromoCell GmbH, STEMCELL Technologies.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Key questions are answered in this report.

  • Which biopharmaceutical companies are active in the bone marrow transplantation market?
  • What will be the SWOT analysis of the bone marrow transplantation market?
  • What are the prevalence rate and clinical manifestations of leukemia, lymphoma, myeloma, and other blood disorders?
  • What is the global incidence rate for lymphoma, and what is the survival rate post-bone marrow transplantation?
  • What is the difference between allogeneic and autologous bone marrow transplantation, and how do they differ in terms of patient clinical manifestations?
  • What will the market size and CAGR be for developing countries in the Asia Pacific, the Middle East, Africa, and Latin America?

Chapter 1. Preface
1.1. Report Scope and Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I-Secondary Research
1.3.2. Phase II-Primary Research
1.3.3. Approach Adopted
1.3.4. Top-down Approach
1.3.5. Bottom-up Approach
1.3.6. Phase III-Expert Panel Review
1.3.7. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global BMT Market Portraiture
2.2. Global BMT Market, by Type, 2017 (US$ Mn)
2.3. Global BMT Market, by Indication, 2017 (US$ Mn)
2.4. Global BMT Market, by Geography, 2017 (US$ Mn)

Chapter 3. Bone Marrow Transplantation (BMT) Market: Dynamics and Future Outlook
3.1. Market Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global BMT Market, by Key Players, 2017

Chapter 4. Global Bone Marrow Transplantation (BMT) Market, by Type
4.1. Overview
4.2. Allogeneic Bone Marrow Transplant
4.3. Autologous Bone Marrow Transplant

Chapter 5. Global Bone Marrow Transplantation (BMT) Market, by Indication
5.1. Overview
5.2. Leukemia
5.3. Lymphoma
5.4. Myeloma
5.5. Others

Chapter 6. Global Bone Marrow Transplantation (BMT) Market, by Geography
6.1. Overview
6.2. North America BMT Market Analysis, 2016 – 2026
6.2.1. North America BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.2.2. North America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.2.3. North America BMT Market, by Country, 2016 – 2026 (US$ Mn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe BMT Market Analysis, 2016 – 2026
6.3.1. Europe BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.3.2. Europe BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.3.3. Europe BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific BMT Market Analysis, 2016 – 2026
6.4.1. Asia Pacific BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.4.2. Asia Pacific BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.4.3. Asia Pacific BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of Asia Pacific
6.5. Latin America BMT Market Analysis, 2016 – 2026
6.5.1. Latin America BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.5.2. Latin America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.5.3. Latin America BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East and Africa BMT Market Analysis, 2016 – 2026
6.6.1. MEA BMT Market, by Type, 2016 – 2026 (US$ Mn)
6.6.2. MEA BMT Market, by Indication, 2016 – 2026 (US$ Mn)
6.6.3. MEA BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. AllCells LLC
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Product Portfolio
7.1.4. News Coverage
7.2. Conversant Bio
7.3. Cellular Dynamics International
7.4. Gamida Cell Ltd.
7.5. Hemacare Corporation
7.6. Lonza Group Ltd.
7.7. Merck Millipore Corporation
7.8. Mesoblast Ltd
7.9. PromoCell GmbH
7.10. STEMCELL Technologies.

List of Figures

FIG. 1 : Bone Marrow Transplantation (BMT) Market: Research Methodology
FIG. 2 : BMT: Market Segmentation
FIG. 3 : Global BMT Market, by Type, 2017 (US$ Mn)
FIG. 4 : Global BMT Market, by Indication, 2017 (US$ Mn)
FIG. 5 : Global BMT Market, by Geography, 2017 (US$ Mn)
FIG. 6 : Attractive Investment Proposition: by Geography, 2017
FIG. 7 : Competitive Analysis: Global BMT Market, by Key Players, 2017
FIG. 8 : Global Allogeneic BMT Market, 2016 – 2026 (US$ Mn)
FIG. 9 : Global Autologous BMT Market, 2016 – 2026 (US$ Mn)
FIG. 10 : Global Leukemia Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 11 : Global Lymphoma Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 12 : Global Myeloma Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 13 : Global Other Indications Market for BMT, 2016 – 2026 (US$ Mn)
FIG. 14 : U.S. BMT Market, 2016 – 2026 (US$ Mn)
FIG. 15 : Canada BMT Market, 2016 – 2026 (US$ Mn)
FIG. 16 : U.K. BMT Market, 2016 – 2026 (US$ Mn)
FIG. 17 : Germany BMT Market, 2016 – 2026 (US$ Mn)
FIG. 18 : Rest of Europe BMT Market, 2016 – 2026 (US$ Mn)
FIG. 19 : China BMT Market, 2016 – 2026 (US$ Mn)
FIG. 20 : Japan BMT Market, 2016 – 2026 (US$ Mn)
FIG. 21 : Rest of Asia Pacific BMT Market, 2016 – 2026 (US$ Mn)
FIG. 22 : Brazil BMT Market, 2016 – 2026 (US$ Mn)
FIG. 23 : Mexico BMT Market, 2016 – 2026 (US$ Mn)
FIG. 24 : Rest of Latin America BMT Market, 2016 – 2026 (US$ Mn)
FIG. 25 : GCC BMT Market, 2016 – 2026 (US$ Mn)
FIG. 26 : Rest of MEA BMT Market, 2016 – 2026 (US$ Mn)

List of Tables

TABLE 1 : Global Bone Marrow Transplantation (BMT) Market Portraiture
TABLE 2 : Global BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 3 : Global BMT Market , by Indication, 2016 – 2026 (US$ Mn)
TABLE 4 : Global BMT Market, by Geography, 2016 – 2026 (US$ Mn)
TABLE 5 : North America BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 6 : North America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 7 : North America BMT Market, by Country, 2016 – 2026 (US$ Mn)
TABLE 8 : Europe BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 9 : Europe BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 10 : Europe BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 11 : Asia Pacific BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 12 : Asia Pacific BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 13 : Asia Pacific BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 14 : Latin America BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 15 : Latin America BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 16 : Latin America BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 17 : Middle East and Africa BMT Market, by Type, 2016 – 2026 (US$ Mn)
TABLE 18 : Middle East and Africa BMT Market, by Indication, 2016 – 2026 (US$ Mn)
TABLE 19 : Middle East and Africa BMT Market, by Country/Region, 2016 – 2026 (US$ Mn)
TABLE 20 : AllCells LLC: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 21 : Conversant Bio: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 22 : Cellular Dynamics International: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 23 : Gamida Cell Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 24 : Hemacare Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 25 : Lonza Group Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 26 : Merck Millipore Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 27 : Mesoblast Ltd.: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 28 : PromoCell GmbH: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)
TABLE 29 : STEMCELL Technologies: Company Snapshot (Business Description; Financial Information; Product Portfolio; Key Developments)

Frequently Asked Questions

What is the size of Bone Marrow Transplantation Market?

The market for Bone Marrow Transplantation Market is expected to reach US$ 13,903.1 Mn by 2026.

What is the Bone Marrow Transplantation Market CAGR?

The Bone Marrow Transplantation Market is expected to see significant CAGR growth over the coming years, at 5.9%.

What is the Forecast period considered for Bone Marrow Transplantation Market?

The report is forecasted from 2018-2026.

What is the base year considered for Bone Marrow Transplantation Market?

The base year of this report is 2017.

Who are the major players in this market?

Conversant Bio, Cellular Dynamics International, Gamida Cell Ltd., Hemacare Corporation, Lonza Group Ltd., Merck Millipore Corporation, Mesoblast Ltd are some of the major players in the global market.

Environmental Testing Equipment Market

Published:
Report ID: 33589

Biological Safety Cabinets Market

Published:
Report ID: 1536

Glycosaminoglycans (GAGs) Market

Published:
Report ID: 33489

Nontuberculous Mycobacterial (NTM) Infection Market

Published:
Report ID: 33051

Sulfated Biomolecules Market

Published:
Report ID: 33398

Plant Stem Cell Market

Published:
Report ID: 9766

Pharmaceutical Rapid Microbiology Testing Market

Published:
Report ID: 9476

Plant Stem Cell Nutrition Products Market

Published:
Report ID: 9775

Biological Data Visualization Market

Published:
Report ID: 32405

Bioprocess Validation Market

Published:
Report ID: 31245

Baculovirus Expression System Market

Published:
Report ID: 31033

Red Biotechnology Market

Published:
Report ID: 30876

Purchase Options

$2999
Delivery Format: Excel.
$4999
Designed for the individual purchaser.
$6999
Users located at a single corporate site or regional office.
$7999
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –

Phone

+91 6232 49 3207


support

24/7 Research Support


sales@credenceresearch.com

– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN